Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 44Gastrointestinal 11Tumor-Agnostic 6CNS 6Dermatologic 5Thoracic 4Sarcoma 4Gynecologic 4Head & Neck 3Endocrine 3Other solid neoplasm 2Other hematologic neoplasm 1NET 1Breast 1

Conditions

Melanoma 5Uveal Melanoma 1Skin Neoplasms 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Axitinib × Dermatologic × Clear all
NCT04996823 2025-12-04

Axitinib + Ipilimumab in Advanced Melanoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting
25 enrolled
Dermatologic

Melanoma, Skin Neoplasms

NCT05070221 2021-10-07

Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis

Peking University Cancer Hospital & Institute

Phase 1 Unknown
30 enrolled
Dermatologic

Melanoma

NCT01321437 2021-01-20

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

University of California, Irvine

Phase 2 Completed
11 enrolled 12 charts
Dermatologic

Melanoma

NCT01174238 2018-06-08

A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma

University of California, San Francisco

Phase 2 Completed
40 enrolled 10 charts
Dermatologic

Melanoma

NCT01533948 2018-05-09

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Roswell Park Cancer Institute

Phase 2 Terminated
25 enrolled 11 charts
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡